Connect with us
Prague Gaming & TECH Summit 2025 (25-26 March)

Fintech PR

Life Reinsurance Market to Reach $731.2 billion, Globally, by 2032 at 12.5% CAGR: Allied Market Research

Published

on

life-reinsurance-market-to-reach-$7312-billion,-globally,-by-2032-at-12.5%-cagr:-allied-market-research

Expansion of insuring capacity, growth in focus on insurers to stabilize losses by limiting risks, and rise in claims in the life insurance sector contribute towards the growth of the market.    

WILMINGTON, Del., Dec. 1, 2023 /PRNewswire/ — Allied Market Research published a report, titled,Life Reinsurance Market by Type (Facultative Reinsurance, and Treaty Reinsurance) and Product Offering (Mortality Solutions, Morbidity Solutions, Longevity Solutions, and Others): Global Opportunity Analysis and Industry Forecast, 2022-2032″. According to the report, the global life reinsurance industry generated $230.7 billion in 2022, and is anticipated to generate $731.2 billion by 2032, witnessing a CAGR of 12.5% from 2023 to 2032.     

Prime determinants of growth  

The life reinsurance market has grown owing to the increasing claims in the life insurance sector. In addition, growth in focus on insurers to stabilize losses by limiting risks and expansion of insuring capacity is fueling the growth of the market. However, the high cost of life reinsurance policy restrains the growth of the market. On the contrary, technological advancement to perform efficiently and increasing awareness about insurance products are expected to provide lucrative opportunities for the market to grow in upcoming years.  

(We are providing report as per your research requirement, including the Latest Industry Insight’s Evolution, Potential and COVID-19 Impact Analysis)

100 – Tables
60 – Charts
321 – Pages

Download Research Report Sample & TOC:
https://www.alliedmarketresearch.com/request-sample/7063 

Report coverage & details:

Report Coverage

Details

Advertisement

Forecast Period

2023–2032

Base Year

2022

Market Size in 2022

$230.7 billion

Market Size in 2032

$731.2 billion

CAGR

12.5 %

Advertisement

No. of Pages in Report

321

Segments covered

Type Product Offering, and Region.

Drivers

Expansion of insuring capacity

Growth in focus on insurers to stabilize losses by limiting risks

Rise in claims in the life insurance sector

Opportunities

Increasing awareness about insurance products

Advertisement

Increased collaboration of Insurtech players

Restraints

High cost of life reinsurance

 

Covid-19 Scenario

  • The pandemic led to a surge in health-related claims, impacting both life and health insurance segments. Reinsurers faced increased claim frequency and severity, especially in regions heavily affected by the virus. The high demand for life and health insurance coverage during the pandemic resulted in a higher volume of claims, requiring reinsurers to carefully manage their exposure.
  • However, the pandemic led to a surge in mortality claims, as the virus resulted in a substantial number of deaths worldwide. Insurers had to pay out claims for life insurance policies, particularly for those who give way to the virus. This led to higher demand for reinsurance capacity to help spread the risk among multiple reinsurers. Therefore, the COVID-19 pandemic had a moderate impact on the life reinsurance market.

The treaty reinsurance segment to maintain its leadership status throughout the forecast period 

By type, the treaty reinsurance segment held the highest market share in 2022, accounting for more than two-third of the global life reinsurance market revenue, owing to the fact that treaty reinsurance helps insurers manage their overall risk exposure across a range of policies, promoting stability and ensuring a more predictable cash flow. However, the facultative reinsurance segment is projected to manifest the highest CAGR of 14.9% from 2023 to 2032, owing to the fact that advancements in data analytics and underwriting technologies have enhanced the ability to assess risks accurately, making facultative reinsurance more efficient and attractive.

Request Customization: https://www.alliedmarketresearch.com/request-for-customization/7063

The mortality solutions segment to maintain its leadership status throughout the forecast period

By product offering, the mortality solutions segment held the highest market share in 2022, accounting for nearly half of the global life reinsurance market revenue and is estimated to maintain its leadership status throughout the forecast period. This is attributed to the fact that advances in medical technology and improved healthcare have resulted in increased life expectancies globally. This trend has necessitated innovative mortality solutions to address the changing landscape of risk. However, the longevity solutions segment is projected to manifest the highest CAGR of 16.6% from 2023 to 2032. This is because the use of advanced analytics and actuarial techniques has improved the accuracy of longevity risk assessment, enabling reinsurers to offer more sophisticated and tailored solutions in this segment.       

North America to maintain its dominance by 2032

Advertisement

By region, North America held the highest market share in terms of revenue in 2022, accounting for more than two-fifth of the global life reinsurance revenue, owing to the fact that insurers and reinsurers in North America are reassessing their risk management strategies, incorporating lessons learned from the pandemic into their contingency planning, and exploring innovative solutions to address future systemic risks. However, the Asia-Pacific region is expected to witness the fastest CAGR of 16.1% from 2023 to 2032 and is likely to dominate the market during the forecast period. This is because the Asia-Pacific region has witnessed significant growth in micro insurance to reach underserved populations. Life reinsurance plays a critical role in supporting insurers as they develop and underwrite these micro insurance products. 

Leading Market Players: –

  • AXA XL
  • Berkshire Hathaway Life
  • Everest Group Ltd.
  • Hannover Re
  • Liberty Mutual Reinsurance
  • Munich Re
  • RGA Reinsurance Company
  • Sompo International Holdings Ltd.
  • Swiss Re
  • The Canada Life Assurance Company

The report provides a detailed analysis of these key players of the global life reinsurance market. These players have adopted different strategies such as partnership, product launch, and expansion to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.

Key benefits for stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the life reinsurance market forecast from 2022 to 2032 to identify the prevailing market opportunities.
  • Market research is offered along with information related to key drivers, restraints, and opportunities of life reinsurance market outlook.
  • Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the life reinsurance market segmentation assists in determining the prevailing life reinsurance market opportunity.
  • Major countries in each region are mapped according to their revenue contribution to the global life reinsurance market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the life reinsurance market players.
  • The report includes an analysis of the regional as well as global life reinsurance market trends, key players, market segments, application areas, and life reinsurance market growth strategies.

Inquire Before Buying: https://www.alliedmarketresearch.com/purchase-enquiry/7063

Life Reinsurance Market Report Highlights

Aspects Details Market

By Type

  • Facultative Reinsurance
  • Treaty Reinsurance

By Product Offering

  • Mortality Solutions
  • Morbidity Solutions
  • Longevity Solutions
  • Others

By Region

  • North America (U.S., Canada)
  • Europe (UK, Germany, France, Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific)
  • LAMEA (Latin America, Middle East, Africa)

Key Market Players: AXA XL, Swiss Re, Sompo International Holdings Ltd., Hannover Re, Munich Re, Liberty Mutual Reinsurance, Berkshire Hathaway Life, The Canada Life Assurance Company, Everest Group, Ltd., RGA Reinsurance Company

Trending Reports in BFSI Industry (Book Now with 10% Discount + COVID-19 Scenario):

Insurance Aggregators Market by Enterprise Size (Large Enterprise, SMEs), by Insurance Type (Life Insurance, Automotive Insurance, Health Insurance, Other): Global Opportunity Analysis and Industry Forecast, 2021-2031

Online Insurance Market by Enterprise Size (Large Enterprises, SMEs), by Insurance type (Life Insurance, Motor Insurance, Health Insurance, Others), by End User (Insurance Companies, Aggregators, Third Party Administrators and Brokers): Global Opportunity Analysis and Industry Forecast, 2021-2031

Property Insurance Market by Coverage (Fire and Theft, House Damage, Floods and Earthquake, Personal Property, Others), by End User (Landlords, Homeowners, Renters, Others), by Application (Personal, Enterprise): Global Opportunity Analysis and Industry Forecast, 2021-2031

Advertisement

Gadget Insurance Market by Coverage Type (Physical Damage, Internal Component Failure, Theft and Loss Protection, Virus and Data Protection, Others), by Device Type (Laptop and PCs, Mobile Phones and Tablets, Home Entertainment Devices, Cameras, Others), by Sales Channel (Retail, Online), by End User (Business, Individuals): Global Opportunity Analysis and Industry Forecast, 2021-2031

P&C Insurance Software Market by Component (Software, Service), by Deployment Model (On Premise, Cloud), by Application (Claims, Underwriting, Operations, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Mobile Phone Insurance Market by Phone Type (Budget Phones, Mid & High-End Phones, Premium Smartphones), by Sales Channel (Retail, Online), by Coverage Type (Physical Damage, Internal Component Failure, Theft & Loss Protection, Others), by End User (Business, Individuals),: Global Opportunity Analysis and Industry Forecast, 2020-2030

Management consulting services market was valued at $316.5 billion in 2021, and is projected to reach $811.3 billion by 2031, growing at a CAGR of 10.2% from 2022 to 2031.

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports Insights” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies, and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Int’l: +1-503-894-6022
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
India (Pune): +91-20-66346060
Fax: +1-800-792-5285
[email protected]
Allied Market Research Blog: https://blog.alliedmarketresearch.com
BFSI Blog

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg

 

Advertisement

Cision View original content:https://www.prnewswire.co.uk/news-releases/life-reinsurance-market-to-reach-731-2-billion-globally-by-2032-at-12-5-cagr-allied-market-research-302003131.html

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

SciBase announces outcome of directed issue and preliminary outcome of rights issue

Published

on

scibase-announces-outcome-of-directed-issue-and-preliminary-outcome-of-rights-issue

STOCKHOLM, Jan. 13, 2025 /PRNewswire/ — SciBase Holding AB (“SciBase” or the “Company”) today announces the preliminary outcome of the capital raise, consisting of a rights issue of units of approximately SEK 59.3 million (the “Rights Issue”) and a directed issue of units, deviating from existing shareholders’ preferential rights, of approximately SEK 22.5 million (the “Directed Issue”), that was announced on  November 12, 2024 (the “Capital Raise”). All 16,669,624 units in the Directed Issue have been subscribed and paid for, and thus the Board of Directors of SciBase plans to resolve on allocation of units to the investors in the Directed Issue on January 14, 2025. The preliminary outcome of the Rights Issue indicates that 22,916,119 units, corresponding to approximately 52.2 percent of the Rights Issue, were subscribed for both with and without the support of unit rights. The Rights Issue was covered to approximately 50.4 percent by subscription commitments, guarantee commitments and declarations of intentions to subscribe for units. Consequently, the guarantee commitments will not be utilized. Through the Rights Issue, the Company will initially receive approximately SEK 30.9 million, and through the Directed Issue the Company will initially receive approximately SEK 22.5 million, before issuance costs. Should all attached warrants of series TO 3 (the “Warrants”), relating to the issued units in the Capital Raise, be exercised, the Company may receive an additional amount of minimum SEK 53.4 million and maximum SEK 89.1 million.

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, BELARUS OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION REQUIRES ADDITIONAL PROSPECTUSES, REGISTRATION OR OTHER MEASURES BEYOND THOSE REQUIRED BY SWEDISH LAW, IS PROHIBITED, OR OTHERWISE CONTRARY TO APPLICABLE RULES IN SUCH JURISDICTION OR CANNOT BE DONE WITHOUT APPLICATION OF EXEMPTIONS FROM SUCH MEASURES. SEE THE SECTION “IMPORTANT INFORMATION” AT THE END OF THIS PRESS RELEASE.

Allocation of units in the Directed Issue

All units in the Directed Issue have been subscribed and paid for, and thus, the Board of Directors of SciBase intends to resolve on the allocation of 16,669,624 units in the Directed Issue, on January 14, 2025, in conjunction with the Company’s resolution on allocation based on the final outcome in the Rights Issue. Each unit in the Directed Issue consists of three (3) shares and three (3) Warrants. Through the Directed Issue, the Company will initially receive approximately SEK 22.5 million before issuance costs.

Outcome in the Rights Issue

The subscription period in the Rights Issue ended on  January 13, 2025 and the preliminary subscription summary indicates that 22,674,031 units, corresponding to approximately SEK 30.6 million, or approximately 51.6 percent of the Rights Issue, were subscribed for with the support of units rights and 242,088 units, corresponding to approximately SEK 0.3 million, or approximately 0.6 percent of the Rights Issue, were subscribed for without the support of unit rights, for a combined total subscription, with and without the support of unit rights, of approximately 52.2 percent. The Rights Issue was covered to approximately 50.4 percent by subscription commitments, guarantee commitments and declarations of intentions to subscribe for units. Consequently, the guarantee commitments will not be utilized. Through the Rights Issue, the Company will initially receive approximately SEK 30.9 million before issuance costs.

Allocation of units in the Rights Issue will be conducted according to the principles specified in the EU growth prospectus issued in connection with the Rights Issue, published on December 20, 2024 (the “Prospectus“). Notifications regarding the allocation of units subscribed without the support of unit rights will be sent via contract notes to those allocated units. Nominee-registered shareholders will receive allocation notifications in accordance with the procedures of each respective nominee.

Number of shares and share capital

As a result of the Rights Issue, the Company’s share capital increases by SEK 3,437,417.85, from SEK 10,976,920.20 to SEK 14,414,338.05, through the issuance of 68,748,357 shares. Thus, the number of shares increases from 219,538,404 to 288,286,761 shares. The dilution effect amounts to 23.8 percent.

Through the Directed Issue, the number of shares in SciBase will increase by 50,008,872 shares, from a total of 288,286,761 shares (calculated on the total number of shares in the Company after the Rights Issue) to a total of 338,295,633 shares. As a result of the Directed Issue, the Company’s share capital will increase by SEK 2,500,443.60, from SEK 14,414,338.05 (calculated on the Company’s share capital after the Rights Issue) to SEK 16,914,781.65. The dilution effect from the Directed Issue amounts to approximately 14.8 percent of the number of shares in the Company (calculated on the total number of shares in the Company after the Rights Issue and the Directed Issue).

Advertisement

Should all Warrants, issued in the Capital Raise, be exercised, the number of shares will increase by an additional 118,757,229 and the share capital will increase by an additional SEK 5,937,861.45, corresponding to an additional dilution effect of approximately 26.0 percent of the total number of shares and votes in the Company (calculated on the total number of shares in the Company after the Rights Issue, the Directed Issue and full exercise of all Warrants).

Trading in BTU

Trading in paid subscribed units (“BTU“) will continue on Nasdaq First North Growth Market up to, and including, January 17, 2025.

Warrants

One (1) Warrant entitles to subscription of one (1) new share in the Company during the period from and including November 24, 2025, until and including, December 5, 2025. The subscription price when exercising the Warrants will be determined as 80 percent of the volume-weighted average price of the Company’s shares on Nasdaq First North Growth Market during the measurement period from and including November 10, 2025, until and including, November 21, 2025, however, no less than SEK 0.45 and no more than SEK 0.75 per share.

Advisors

SciBase has engaged Penser by Carnegie as financial advisor and Advokatfirman Schjødt as legal advisor in connection with the Capital Raising.

Certified Advisor (CA):

Carnegie Investment Bank AB (publ)
Phone: +46 (0)73 856 42 65
E-mail: [email protected]

For additional information, please contact:
Pia Renaudin, CEO, tel. +46732069802, e-mail: [email protected] 

Advertisement

The information was submitted for publication, through the agency of the contact person set out above, at 8.00 PM on January 13, 2025.

About SciBase

SciBase is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase develops and commercializes Nevisense, a unique point-of-care platform that combines AI (artificial intelligence) and advanced EIS technology to enhance diagnostic accuracy, ensuring proactive skin health management.

Our commitment is to minimize patient suffering, allowing clinicians to improve and save lives through timely detection and intervention and reduce healthcare costs.

Built on more than 20 years of research at Karolinska Institute in Stockholm, Sweden, SciBase is a leader in dermatological advancements.

The Company has been listed on Nasdaq First North Growth Market since June 2, 2015, and the Certified Advisor is Carnegie Investment Bank AB (publ). For more information, visit www.SciBase.com. All press releases and financial reports can be found here: http://investors.scibase.se/sv/pressmeddelanden.

Important information

Publication, release or distribution of this press release may in certain jurisdictions be subject to legal restrictions and persons in the jurisdictions where this press release has been made public or distributed should be informed of and follow such legal restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with applicable rules in each jurisdiction. This press release does not constitute an offer or solicitation to buy or subscribe for any securities in SciBase in any jurisdiction, either from SciBase or from anyone else.

This press release is not a prospectus according to the definition in Regulation (EU) 2017/1129 (the “Prospectus Regulation“) and has not been approved by any regulatory authority in any jurisdiction. Acquisition of Units in the Rights Issue should only be made on the basis of the information in the formal Prospectus published by the Company in connection with the Rights Issue and which is made available on the Company’s website, https://investors.scibase.se/en/mid-disclaimer/107/83.

This press release does not constitute an offer or solicitation to buy or subscribe for securities in the United States. The securities mentioned herein may not be sold in the United States without registration, or without an exemption from registration, under the U.S. Securities Act from 1933 (“Securities Act“) and may not be offered or sold within the United States without being registered, covered by an exemption from, or part of a transaction that is not subject to the registration requirements according to the Securities Act. There is no intention to register any securities mentioned herein in the United States or to issue a public offering of such securities in the United States. The information in this press release may not be released, published, copied, reproduced or distributed, directly or indirectly, wholly or in part, in or to Australia, Belarus, Canada, Hong Kong, Japan, New Zealand, Russia, Switzerland, Singapore, South Africa, the United States or any other jurisdiction where the release, publication or distribution of this information would violate current rules or where such an action is subject to legal restrictions or would require additional registration or other measures beyond those that follow from Swedish law. Actions in contravention of this instruction may constitute a violation of applicable securities legislation.

Advertisement

Forward-looking statements

This press release contains forward-looking statements related to the Company’s intentions, estimates or expectations with regard to the Company’s future results, financial position, liquidity, development, outlook, estimated growth, strategies and opportunities as well as the markets in which the Company is active. Forward-looking statements are statements that do not refer to historical facts and can be identified by the use of terms such as “believes,” “expects,” “anticipates,” “intends,” “estimates,” “will,” “may,” “implies,” “should,” “could” and, in each case, their negative, or comparable terminology. The forward-looking statements in this press release are based on various assumptions, which in several cases are based on further assumptions. Although the Company believes that the assumptions reflected in these forward-looking statements are reasonable, there is no guarantee that they will occur or that they are correct. Since these assumptions are based on assumptions or estimates and involve risks and uncertainties, actual results or outcomes, for many different reasons, may differ materially from those what is stated in the forward-looking statements. Due to such risks, uncertainties, eventualities and other significant factors, actual events may differ materially from the expectations that expressly or implicitly are contained in this press release through the forward-looking statements. The Company does not guarantee that the assumptions which serve as a basis for the forward-looking statements in this press release are correct, and each reader of the press release should not rely on the forward-looking statements in this press release. The information, opinions and forward-looking statements that expressly or implicitly are stated herein are provided only as of the date of this press release and may change. Neither the Company nor any other party will review, update, confirm or publicly announce any revision of any forward-looking statement to reflect events that occur or circumstances that arise with respect to the contents of this press release, beyond what is required by law or Nasdaq First North Growth Market Rulebook for Issuers of Shares.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/scibase/r/scibase-announces-outcome-of-directed-issue-and-preliminary-outcome-of-rights-issue,c4090867

The following files are available for download:

View original content:https://www.prnewswire.co.uk/news-releases/scibase-announces-outcome-of-directed-issue-and-preliminary-outcome-of-rights-issue-302349666.html

Continue Reading

Fintech PR

Strategic Value Partners invests €200 million in Bjelin Group

Published

on

strategic-value-partners-invests-e200-million-in-bjelin-group

HELSINGBORG, Sweden, Jan. 13, 2025 /PRNewswire/ — Strategic Value Partners, LLC (together with its affiliates, “SVP”), a global alternative investment firm with approximately $19 billion of assets under management, and Bjelin Group today announced the signing of an agreement whereby funds managed by SVP will make a €200 million preferred equity investment in Bjelin Group to facilitate its long-term growth ambitions.

Bjelin Group AB is fully owned by the Pervan family and its assets comprise a 51% ownership stake in Välinge Group and a 100% ownership stake in Bjelin Industries. 49% of the shares of Välinge Group are owned by KIRKBI Invest A/S and Välinge Group management.

Välinge Group has two business segments. A licensing business for flooring and furniture applications (Välinge Innovation AB) and an industrial business with large scale production of flooring with Woodura® surface technology and furniture in Sweden and Croatia. Bjelin Industries is a veneer, flooring and furniture manufacturing business with production facilities in Croatia.

Bjelin Group AB will acquire all shares in Välinge’s industrial business, which will be merged with Bjelin Industries. The acquisition is expected to be completed during the first quarter of 2025, pending customary closing conditions and governmental approval. Funds managed by SVP will make a €200 million preferred equity investment in Bjelin Group to finance this acquisition and provide capital for additional major investments in Woodura® and veneer production with the aim to create a world leading sustainable wood flooring company. The Pervan family will maintain an ownership stake of 97% in Bjelin Group AB.

Välinge Innovation AB, which is a leading R&D, IP and licensing company, mainly related to flooring and furniture technology, anticipates that it will seek a public listing at the appropriate time as the potential high growth of Woodura® flooring is expected to benefit Välinge’s license revenues.

“Our partnership with SVP is more than a financial investment. Bjelin Industries has a key relationship with SVP’s portfolio company, Pfleiderer, a leading manufacturer of high-quality wood-based products including HDF which is used as a core in our Woodura® flooring, laminates for kitchen, furniture, and construction applications. We are excited about the potential to expand the collaboration between Pfleiderer and Bjelin with a wide range of potential commercial and technical cooperation opportunities. Fredrik Alfredsson, who has a long international experience within the flooring business, will be appointed CEO of Bjelin Group,” said Darko Pervan, Chairman and founder of Bjelin Group.

Brian Himot, Head of Structured Capital at SVP, said: “Over the past 30 years, Darko Pervan has built a leading IP licensing business and set the foundations to create a market leading industrial manufacturing business. We are delighted to be partnering with an entrepreneur of his standing at a key moment for the development of the manufacturing business. SVP has developed expertise in these types of partnership-oriented investments with founders and family offices. We look forward to working closely with the Pervan family to drive value for the business.”

“During the past 7 years we have been involved in large scale Woodura® production, and a major part of our license revenues have been invested to develop and commercialize this sustainable and competitive flooring technology. Välinge and Bjelin have invested about €500 million to build large-scale production and marketing capabilities and to secure the oak material which is used as a surface in floors with Woodura® technology. This has provided a lot of new knowledge and patents. Our work to scale up the technology is now complete, and we are convinced that our industrial group combined with Bjelin Industries will be very successful.  We believe that this will increase our license revenues and will give a very good long-term return on our investment,” said Niclas Håkansson, CEO of Välinge Innovation AB.

Citi and Nordea acted as joint placement agents. SVP was advised by Kirkland and Ellis, Schjødt and Wolf Theiss as legal counsel. Bjelin Group was advised by Mannheimer Swartling as legal counsel.

The Woodura® word mark and logo are registered trademarks owned by Välinge Innovation AB and any use of such marks is under license.

Advertisement

About SVP

SVP is a global alternative investment firm that focuses on special situations, private equity, opportunistic credit and financing opportunities. The firm uses a combination of sourcing, financial and operational expertise to unlock value in its portfolio companies. Today SVP manages approximately $19 billion in assets under management, and since inception, has invested more than $50 billion of capital, including more than $18 billion in Europe. The firm, established by Victor Khosla in 2001, has over 200 employees, including more than 100 investment professionals, across its main offices in Greenwich (CT) and London, and a presence in Tokyo. Learn more at www.svpglobal.com

Contact:
Greenbrook
James Madsen / Ksenia Galouchko
[email protected]

View original content:https://www.prnewswire.co.uk/news-releases/strategic-value-partners-invests-200-million-in-bjelin-group-302349646.html

Continue Reading

Fintech PR

HashKey Receives In-Principle Approval for Dubai VASP License

Published

on

hashkey-receives-in-principle-approval-for-dubai-vasp-license

HONG KONG, Jan. 13, 2025 /PRNewswire/ — HashKey Group (“HashKey”), a leading end-to-end digital asset financial services group in Asia, today announced that HashKey MENA FZE, a member of the HashKey Group, has received an In-Principle Approval (IPA) from the Dubai Virtual Assets Regulatory Authority (VARA) for its Virtual Asset Service Provider (VASP) license application. This regulatory approval reinforces HashKey Group’s position as a trusted leader in the virtual asset industry, enabling HashKey to deliver secure and transparent services globally.

Upon final approval, the VASP license will authorise HashKey MENA FZE to offer Virtual Asset Exchange Services and Virtual Asset Broker-Dealer Services in and from the Emirate of Dubai to retail investors, qualified investors, and institutional investors. This milestone also marks significant progress for HashKey OTC, the Group’s over-the-counter trading arm, as it expands its regulated offerings in the Middle East. In doing so, HashKey OTC underscores its commitment to a compliance-first approach, offering investors a secure and efficient environment for digital asset trading.

Ben El-Baz, Managing Director of HashKey Global said “We view this milestone as a pivotal moment for us, as it positions us in the future to serve both retail and institutional clients in the UAE with enhanced accessibility and local currency support. This achievement empowers us to deliver trusted, compliant, and seamless virtual asset services, enabling clients to deposit and withdraw in their local currency. At HashKey Global, we are deeply committed to fostering growth in Dubai and the broader MENA region by combining regulatory excellence and a customer-first approach. This marks the beginning of an exciting journey to drive sustainable growth and build lasting relationships in this dynamic market.”

HashKey Group holds licenses in Hong Kong, Singapore, Japan, and Bermuda, has a VASP registration in Ireland, and is actively pursuing a MiCA license in Europe to further strengthen its global regulatory footprint.

About HashKey Group

HashKey Group is a leading digital asset financial services group in Asia with global operations in regions such as Hong Kong, Singapore, Japan, Ireland and Bermuda. Since 2018, HashKey Group has built a global Web3 ecosystem within a high-compliance regulatory framework, including HashKey Exchange, a licensed virtual asset exchange regulated by the Hong Kong SFC; HashKey Global, the global flagship digital asset exchange; HashKey Capital, a global asset manager investing exclusively in blockchain technology and digital assets; HashKey OTC, the compliant over-the-counter (OTC) trading arm of HashKey Group, HashKey Cloud, a leading provider of global Web3 infrastructure; and HashKey Tokenisation, a tokenisation services provider.

HashKey Group also possesses a rich on-chain ecosystem, having developed the Ethereum Layer 2, HashKey Chain, and has listed the HashKey platform token HSK. HashKey Group is committed to driving the mass application of blockchain technology, aiming to provide trustworthy and accessible digital asset services to one billion global users.

Disclaimer

Please be aware that certain services, features, and campaigns may not be available in your jurisdiction. In particular, digital asset exchanges operated under HashKey Group does not service clients from Hong Kong (for HashKey Global), Mainland China and the United States and certain other jurisdictions in compliance with laws and regulations. HashKey is subject to the regulatory approval and receipt of the Financial Services Permission

About HashKey OTC

Advertisement

HashKey OTC is a leading provider of bespoke digital asset trade execution services, offering a secure and regulated trading environment for institutional and professional clients. With a strong emphasis on compliance and security, HashKey OTC delivers spot trades, crypto on/off ramp services, and access to a diverse range of digital assets and fiat currencies.

For media inquiries, please visit: Website | X | Telegram 

Disclaimer: The information shared in this article is for general informational purposes only. Nothing shared in this article constitutes an offer, recommendation, or solicitation to buy, sell, or engage in any specific asset or investment strategy.

About HashKey Global

HashKey Global is the flagship digital asset exchange under HashKey Group, offering licensed digital asset trading services to users worldwide, and becomes one of the fastest-growing crypto exchanges in 2024. HashKey Global has obtained a license from the Bermuda Monetary Authority providing mainstream trading and service products such as LaunchPad, contracts, leverage, etc.

Please read our latest Disclaimer.
For more details, please visit global.hashkey.com   
Follow HashKey on  X, Telegram, and Discord

View original content:https://www.prnewswire.co.uk/news-releases/hashkey-receives-in-principle-approval-for-dubai-vasp-license-302349440.html

Continue Reading

Trending